Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Medical Device Affairs Outsourcing Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The medical device affairs outsourcing market has shown significant growth in recent years. Its valuation is expected to rise from $5.45 billion in 2025 to $5.85 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. Historically, this expansion has been driven by increasing regulatory complexities, a reliance on in-house regulatory teams, a growing number of medical device approvals, the expansion of global medical device markets, and a heightened awareness of compliance risks.
The medical device affairs outsourcing market is projected to experience substantial expansion over the coming years. By 2030, its valuation is set to reach $7.65 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth is primarily fueled by factors such as the increasing uptake of sophisticated regulatory software solutions, a rise in collaborative outsourcing agreements, a heightened emphasis on strategic regulatory foresight, the broadening of post-market surveillance initiatives, and the integration of AI and analytics to boost regulatory effectiveness. Noteworthy trends emerging in this period include a growing reliance by medical device firms on regulatory affairs outsourcing, an escalating need for cloud-powered compliance and management tools, an effort to simplify clinical trial applications and regulatory filings, an increase in support services for Quality Management Systems (QMS), and improved post-market monitoring and risk evaluation functionalities.
Get A Free Sample Report With In-Depth Market Insights:
Medical Device Affairs Outsourcing Market Demand Drivers Opening New Revenue Streams
The growing need for medical devices is projected to stimulate the expansion of the medical device affairs outsourcing market in the coming years. Medical devices include instruments, apparatuses, machines, or implants employed for the diagnosis, treatment, or prevention of various health conditions. The heightened demand for these devices is mainly attributed to improved treatment effectiveness, superior patient outcomes, and the proliferation of healthcare facilities. Medical device affairs outsourcing assists in streamlining operations, reinforcing compliance, and improving market results, thereby allowing companies to prioritize innovation and growth by leveraging external expertise for vital functions. For example, in April 2024, The Medicines and Healthcare products Regulatory Agency (MHRA), a UK-based government agency, recorded an increase in registered medical products from approximately 2.25 million in 2022 to around 3.25 million in 2024. Therefore, the rising demand for medical devices is a significant impetus for the medical device affairs outsourcing market.
Medical Device Affairs Outsourcing Market Segmentation: How Does The Market Break Down By Category?
The medical device affairs outsourcing market covered in this report is segmented –
1) By Service: Regulatory Writing And Submissions, Regulatory Registration Services, Regulatory Consulting, Other Services
2) By Software: Cloud Based Software, On Premise Software
3) By End User: Pharmaceutical Companies, Medical Technology Companies, Other End Users
Subsegments:
1) By Regulatory Writing And Submissions: Clinical Trial Applications (CTAs), Investigational New Drug Applications (INDs), New Drug Applications (NDAs), Summary And Reports For Regulatory Agencies
2) By Regulatory Registration Services: Device Registration, Market Authorization Applications (MAAs), Product Listing And Establishment Registration
3) By Regulatory Consulting: Strategic Regulatory Planning, Regulatory Compliance Audits, Labeling And Advertising Compliance
4) By Other Services: Post-Market Surveillance, Training And Education, Quality Management System (QMS) Support, Risk Management And Assessment
Medical Device Affairs Outsourcing Market Trends Powering Strategic Industry Growth
Key players within the medical device affairs outsourcing market are striving to enhance decentralized clinical trials, aiming to improve the efficiency and flexibility of clinical research, boost patient recruitment and retention, and streamline data collection and analysis processes. A decentralized clinical trial (DCT) describes a clinical trial framework that supports the medical device industry by delivering specialized services that elevate the efficiency, compliance, and overall effectiveness of clinical trials, which are indispensable for bringing novel medical devices to market. Illustratively, in March 2023, Syneos Health, a US-based entity offering contract research and commercial services to pharmaceutical and biotechnology companies, launched a Decentralized Clinical Trial (DCT) Site Network. This endeavor was designed to foster the adoption and quality of decentralized clinical trials, reflecting a dedication to advancing decentralized solutions in clinical trials, ultimately enhancing patient involvement and trial outcomes. This integrated approach aids in collecting robust evidence and real-world insights, which are crucial for successful commercialization strategies.
Medical Device Affairs Outsourcing Market Key Participants And Competitive Landscape
Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC
View The Full Medical Device Affairs Outsourcing Market Report:
Medical Device Affairs Outsourcing Market Geographic Analysis: Where Is Demand Rising Fastest?
Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
